President and CEO of ONCOGENEX PHARMACEUTICALS INC. - COMMON SHARES (OGXI, Financial) Scott Daniel Cormack sells 5,000 shares of OGXI on 11/01/2010 at an average price of $15.45 a share.
Oncogenex Pharmaceuticals Inc. - Common Shares has a market cap of $105.9 million; its shares were traded at around $16.39 with and P/S ratio of 4.
OGXI is in the portfolios of Jean-Marie Eveillard of First Eagle Investment Management, LLC, Jim Simons of Renaissance Technologies LLC, Steven Cohen of SAC Capital Advisors.
Oncogenex Pharmaceuticals Inc. - Common Shares has a market cap of $105.9 million; its shares were traded at around $16.39 with and P/S ratio of 4.
OGXI is in the portfolios of Jean-Marie Eveillard of First Eagle Investment Management, LLC, Jim Simons of Renaissance Technologies LLC, Steven Cohen of SAC Capital Advisors.
Directors and Officers Recent Trades:
- Sell: Former Director Michael A Martino sold 2,557 shares of OGXI stock on 07/06/2010 at the average price of 13.02. Michael A Martino owns at least 11,000 shares after this. The price of the stock has increased by 25.88% since.
- Sell: Director Michael A Martino sold 14,000 shares of OGXI stock on 06/03/2010 at the average price of 14.46. Michael A Martino owns at least 11,000 shares after this. The price of the stock has increased by 13.35% since.
- Sell: Director Michael A Martino sold 1,500 shares of OGXI stock on 05/18/2010 at the average price of 18.18. Michael A Martino owns at least 11,000 shares after this. The price of the stock has decreased by 9.85% since.
- Sell: Director Dwight Winstead sold 25,260 shares of OGXI stock on 05/17/2010 at the average price of 18.57. The price of the stock has decreased by 11.74% since.
- Sell: Director Michael A Martino sold 13,094 shares of OGXI stock on 05/17/2010 at the average price of 18.67. Michael A Martino owns at least 11,000 shares after this. The price of the stock has decreased by 12.21% since.
